Tissue- and organ-specific immune responses: Role in human disease and allograft immunity

Transplantation Reviews

Volumn 10, Issue 1, 1996, Pages 34-45

  Calhoun, Royce ^a   Mohanakumar, T ^a   Flye, M Wayne ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004942608     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(96)80004-8     Document Type: Article

References (75)

1. Bjorkman PJ, Saper MA, Samraouri B, et al: Structure of the HLA class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506
2. Townsend AR, Rothbard J, Gotch FM, et al: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986, 44:959
3. Monaco JJ: A molecular model of MHC class I-restricted antigen processing. Immunol Today 1992, 13:173
4. 2-m complexes associates with TAP transporters before peptide binding. Nature 1994, 368:864
5. Neefjes JJ, Pleogh HL: Intracellular transport of MHC class II molecules. Immunol Today 1992, 13:179
6. Marrack P, Kappler J: T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 1988, 332:840
7. Bernhard EJ, Le A, Barbosa J, et al: Cytotoxic T cells from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells. J Exp Med 1988, 168:1157
8. Heath WR, Hurd M, Carbone F, et al: Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 1989, 341:749
9. Heath WR, Sherman LA: Cell-type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: A consequence of peptide-dependent allorecognition. Eur J Immunol 1991, 21:153
10. Mohanakumar T, Phibbs M, Haar J, et al: Alloantibodies eluted from rejected human renal allografts: Reactivity to primary kidney cells in culture. First National Workshop on Organ Specific Alloantigens. Transplant Proc 1980, 12:65
11. Vegt PA, Buurman WA, van der Linden CJ, et al: Cell-mediated cytotoxicity toward canine kidney epithelial cells. Transplantation 1982, 33:465
12. Manca F, Barocci S, Kunkl A, et al: Recognition of donor fibroblast antigens by lymphocytes homing in the human grafted kidney. Transplantation 1983, 36:670
13. Yard BA, Kooymans-Couthino M, Reterink T, et al: Analysis of T cell lines from rejecting renal allografts. Kidney Int 1993, 43:S133 (suppl)
14. Hadley GA, Linders B, Mohanakumar T: Immunogenicity of MHC class I alloantigens expressed on parenchymal cells in the human kidney. Transplantation 1992, 54:537
15. Hadley GA, Mohanakumar T: Kidney cell-restricted recognition of MHC class I alloantigens by human cytolytic T cell clones. Transplantation 1993, 55:400
16. Matzinger P, Bevan MJ: Hypothesis why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 1977, 29:1
17. Falk K, Rotzschke O, Rammensee HG: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990, 348:248
18. Falk K, Rotzcchke O, Stevanovic S, et al: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290
19. Poindexter NJ, Naziruddin B, McCourt DW, et al: Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL. J Immunol 1995, 154:3880
20. DiBrino M, Parker KC, Shiloach J, et al: Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci USA 1993, 90:1508
21. Poindexter NJ, Steward NS, Shenoy S, et al: Cytolytic T lymphocytes from human renal allograft biopsies are tissue specific. Hum Immunol 1995, 44:43
22. Beck Y, Sekimata M, Nakayama S, et al: Expression of human minor histocompatibility antigens on cultured kidney cells. Eur J Immunol 1993, 23:467
23. Bortin MM: A compendium of reported human bone marrow-transplants. Transplantation 1970, 9:571
24. Goulmy E, Gratama JW, Blokland E, et al: A minor transplant antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host-disease. Nature 1983, 302:159
25. van Els CACM, D'Amaro J, Pool J, et al: Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance. Immunogenetics 1992, 35:161
26. deBueger M, Bakker A, van Rood JJ, et al: Tissue distribution of human minor histocompatibility antigens: Ubiquitous versus restricted tissue distribution indicates heterogeneity among human CTL-defined non-MHC antigens. J Immunol 1992, 149:1788
27. van der Harst, Goulmy E, Falkenburg JH, et al: Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemia cells by cytotoxic T-cell clones. Blood 1994, 84:1060
28. deBueger M, Goulmy E: Human minor histocompatibility antigens. Transplant Immunol 1993, 1:28
29. den Haan JMM, Sherman NE, Blokland E, et al: Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995, 268:1476
30. Stock PG, Meloche M, Ascher N, et al: Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic β-cells in absence of Ia+ dendritic cells. Diabetes 1989, 38:S161 (suppl)
31. Shiroki R, Poindexter NK, Woodle S, et al: Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. Transplantation 1994, 57:1555
32. Moraes JR, Stastny P: Allo-antibodies to endothelial cell antigens, in Kissmeyer-Nielsen F (ed): Histocompatibility Testing. Copenhagen, Denmark, Munksgaard, 1975, p 391
33. Wang XM, Zhong HP, Zhou SF, et al: Detection of antivascular endothelial cell antibodies with microcytotoxicity testing. J Clin Lab Immunol 1989, 28:73
34. Paul LC, Claas FH, van Es LA, et al: Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens or endothelium and monocytes. N Engl J Med 1979, 300:1258
35. Cerilli J, Clarke J, Doolin T, et al: The significance of a donor-specific vessel crossmatch in renal transplantation. Transplantation 1988, 46:359
36. Leichter HE, Ettenger RB, Robertson L, et al: Significance of the monocyte crossmatch in living related transplant. Child Nephrol Urol 1990, 10:186
37. Trento A, Hardesty RL, Griffith BP, et al: Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplant. J Thorac Cardiovasc Surg 1988, 95:37
38. Maisch B, Weyerer O, Hufnagel G, et al: The vascular endothelium as target of humoral auto-reactivity in myocarditis and rejection. Zeitschrift Fur Kardiologie 1989, 78:95 (suppl 6)
39. Brasile L, Clarke J, Cerilli J: A probable mechanism for allograft rejection in HLA-identical combinations. Transplant Proc 1987, 19:894
40. Mohanakumar T, Waldrep JC, Phibbs M: Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 1981, 32:61
41. Paul L, van Es L, van Rood J, et al: Antibodies directed against antigens or the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation 1979, 37:175
42. Schook LB, Wood NL, Mohanakumar T: Identification of human vascular endothelial cell/monocyte antigenic system using monoclonal antibodies. Transplantation 1987, 44:412
43. k haplotype. J Immunol 1981, 126:1747
44. Steinmuller D, Tyler JD: Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. 2. Genetic basis of the response of C3H mice. J Immunol 1981, 126:754
45. So SKS, Wilkes LM, Platt JL, et al: Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. Transplant Proc 1987, 19:251
46. Steinmueller D: Tissue-specific and tissue-restricted histocompatibility antigens. Immunol Today 1984, 5:234
47. Maron R, Zerubavel R, Friedman A, et al: T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune throiditis in mice. J Immunol 1983, 131:2316
48. Mackenzie WA, Davies TF: An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunology 1987, 61:101
49. Mariotti S, Chiovato L, Vitti P: Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 1989, 50:S73 (suppl)
50. Mullins RJ, Chernajovsky Y, Dayan C, et al: Transfection of thyroid autoantigens into EBV-transformed B cell lines. J Immunol 1994, 152:5572
51. Ropars A, Marion S, Takorabet L: Antibodies specific for human thyrotropin receptor induce MHC antigen expression in thyroid cells. J Immunol 1994, 153:3345
52. Faustman D: Mechanisms of autoimmunity in type I diabetes. J Clin Immunol 1993, 13:1
53. Harrison LC: Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 1992, 13:348
54. Honeyman MC, Cram DS, Harrison LC: Glutamic acid decarboxylase 67-reactive T cells: A marker of insulin-dependent diabetes. J Exp Med 1993, 177:535
55. Goss JA, Nakafusa Y, Yu S, Flye MW: Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Transplantation 1993, 56:166
56. Gerling IC, Serreza DV, Christianson SW, et al: Intrathymic islet cell transplantation reduces beta cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 1992, 41:1672
57. Nomura Y, Stein E, Mullen Y: Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobesc diabetic (NOD) mice. Transplantation 1993, 56:638
58. Posselt AM, Naji A, Roark JH, et al: Intrathymic islet transplantation in the spontaneously diabetic BB rat. Ann Surg 1991, 214:363
59. Kaufman DL, Clare-Salzler M, Tian J, et al: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366:69
60. Tisch R, Yang XD, Singer SM, et al: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993, 366:72
61. Panina-Bordignon P, Lang R, van Endert PM, et al: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 1995, 181:1923
62. Klareskog L, Olsson T: Autoimmunity to collagen II and myelin basic protein: Comparative studies in humans and rodents. Immunol Rev 1990, 118:285
63. Molter E, Bohme J, Valugird MA, et al: Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev 1990, 118:5
64. Foley EJ: Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Research 1953, 13:835
65. Peoples GE, Schoof DD, Andrews JV, et al: T cell recognition of ovarian cancer. Surgery 1993, 114:227
66. Van der Bruggen P, Traversari C, Chomez P, et al: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254:1643
67. Traversari C, van der Bruggen P, Leuscher IF, et al: A nonapeptide encoded by human gene MAGE-1 is recognized by HLA-A1 cytolytic lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992, 176:1453
68. Gaugler B, van den Eynde B, van der Bruggcn P, et al: Human gene Mage-3 codes for an antigen recognized on melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994, 179:921
69. Slingluff CL Jr, Cox AL, Henderson RA, et al: Recognition of human melanoma cells by HLA-A2.1 restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 1992, 150:2955
70. Cox AL, Skipper J, Chen Y, et al: Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994, 264:716
71. Kwon BS, Chintamaneni C, Kozak CA, et al: A melanocyte-specific gene, Pmel 17, maps near the silver coat color focus on mouse chromosome 10 and is in a syngenic region on human chromosome 12. Proc Natl Acad Sci USA 1991, 88:9228
72. Everson TC, Cole WH (eds): Spontaneous Regression of Cancer. Philadelphia, PA, Saunders, 1966
73. Richards JM, Mehta N, Ramming K, et al: Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 1992, 10:1338
74. Celis E, Fikes J, Wentworth P, et al: Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Molec Immunol 1994, 31:1423
75. Kawakami Y, Eliyahu S, Sakaguchi K, et al: Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994, 180:347